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ABSTRACT

SCREENING FOR BINDING PARTNERS AND PROTEIN-PROTEIN INTERACTIONS OF
A FUNGAL TRANSCRIPTION FACTOR- XDR1
FEBRUARY 2022

NISHADI PUNSARA GALLALA GAMAGE, B. S., UNIVERSITY OF COLOMBO

M. S., UNIVERSITY OF MASSACHUSETTS AMHERST

Directed by: Professor Geunhwa Jung

Clarireedia spp. (formerly Sclerotinia homoeocarpa F.T. Bennett) is the causal agent
dollar spot, the most economically important turfgrass disease impacting golf courses in North
America. The most effective strategy for dollar spot control is repeated application of multiple
classes of fungicides. However, reliance on chemical application has led to resistance to four
classes of fungicides as well as multidrug resistance (MDR). Fungi are known to detoxify
xenobiotics, like fungicides, through transcriptional regulation of three detoxification phases:
modification, conjugation and secretion. Little is known, however, of the protein-protein
interactions that facilitate these pathways. Following next-generation RNA sequencing of
Clarireedia spp., a fungus-specific transcription factor, XDR1, was determined to play a role in
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constitutive and induced overexpression of phases I and III genes of xenobiotic detoxification.
Further, a novel activation domain (AD) on XDR1 that does not directly bind with xenobiotics
was confirmed to be highly conserved among fungal species. Therefore, we hypothesize that
XDR1 must be activated by interacting with other binding partners at this AD in order to regulate
downstream xenobiotic detoxification pathways. The main objective of this study is to identify
additional proteins/ co-repressors that activate XDR1 in order to gain a better understanding of
how transcriptional regulation of xenobiotic detoxification pathways leads to MDR.
In order to test the hypothesis, fungicide sensitive strain (HRS10) and fungicide resistant
strain (HRI11) were transformed and tagged with xdr1/XDR1 and the 3xFLAG tag. As a result,
four fungal transformants were generated and those are HRS10-XDR1-3xFLAG, HRS10-xdr13xFLAG, HRI11-XDR1-3xFLAG, and HRI11-xdr1-3xFLAG. The total protein extractions
(whole cell lysates) were subjected to co-immunoprecipitation and the samples were analyzed
using LC-MS/MS. According to the set of results, more than 50 proteins were detected with
HRS10-XDR1-3xFLAG with and most of these binding partners having functions related to post
translational modification, protein turnover, intracellular trafficking, secretion and vascular
transport. Going forward, information gained from this experiment could be used to explore how
XDR1 interacts with its binding partners to facilitate the transcription of drug metabolizing genes
responsible for multidrug resistance. This information could also help identify additional fungicide
metabolism pathways in filamentous fungi.
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1. INTRODUCTION AND BACKGROUND

Introduction to dollar spot and fungicide resistance
Dollar spot is an ascomycete fungus caused by Clarireedia spp. (formally known as
Sclerotinia homoeocarpa F. T. Bennett) (Salgado-Salazar et al., 2018). Dollar spot is the most
economically important pathogen on cool season turfgrasses in North America and has a unique
appearance of bleaching of the leaf blades (Smiley et al., 2005). As symptoms, individual leaf
blades can contain small lesions or one large lesion and therefore the entire leaf blade may get
damaged. Infected leaves expand and coalesce to make circular sunken patches of white to strawcolor. Patches have diameter 0.5 to less than 4 inches similar diameter to a dollar coin, therefore
named as dollar spot (Allen et al., 2005). Dollar spot can infect and cause considerable damage to
annual bluegrass (Poa annua L.) and creeping bentgrass (Agrostis palustris Huds) on golf course
fairways, tee boxes, putting greens and also home lawns (Goodman and Burpee, 1991). The
mycelia present both in and outside of the leaf blades and can be spread through mowing and
maintenance equipment, foot and carts (Liberti et al., 2012).
Cultural practices like dew removal, frequent rolling and addition of nitrogen fertilizers are
often used to manage dollar spot but these methods are typically inefficient and do not maintain
high turf quality (Delvalle et al., 2011). Therefore, application of fungicides is required in order to
obtain acceptable control of dollar spot (Popko et al., 2018). Effective fungicide classes for
controlling dollar spot include benzimidazoles, dicarboximides, demethylation inhibitors (DMIs),
succinate dehydrogenase inhibitors (SDHIs) and uncouplers of oxidative phosphorylation
(Inguagiato and Martin, 2015). Benzimidazoles or methyl benzimidazole carbamates (MBC)
inhibit the microtube assembly during the mitosis therefore inhibit the nuclear division (Wong et
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al., 2008). Dicarboximides have an effect on osmo-sensing systems of the fungi, but the mode of
action is not yet clear (Fillinger et al., 2012). DMI fungicides inhibit the demethylation of
lanosterol by inhibiting the sterol 14α-demethylase enzyme (CYP51) and arrest the cell membrane
integrity (Popko et al., 2012). SDHI fungicides inhibit succinate dehydrogenase enzyme complex
comprised of four subunits and arrest the electron transport chain leading to less energy production
(Popko et al., 2018).
Through various mechanisms, phytopathogenic fungi can develop resistance to fungicides
causing major problems in the crop industry. Single or multiple mutations in the genes targeted by
the fungicides may lead to resistance in which the fungi lose the sensitivity to them, and therefore
overcoming the fungicide (Ma and Michailides, 2005). These mechanisms include reduced
fungicide binding due to target site changes, alternative enzyme synthesis replacing the target
enzyme, target enzyme overproduction, reduction of fungicide consumption, and fungicide
metabolism (Fluit et al., 2001; Ma and Michailides, 2005; McGrath, 2001).
After introducing dicarboximides to turf industry during the mid-1970’s, dicarboximide
resistance in dollar spot was first reported at a Michigan golf course using iprodione (Detweiler et
al., 1983). Because dicarboximides function by interfering with group III histidine kinase and
downstream MAP kinase by osmoregulation, mutations in group III histidine kinase resulted in
dicarboximide resistance (Avenot et al., 2005; Fillinger et al., 2012; Ma et al., 2007). After the
late-1970’s, DMI fungicides became increasingly popular for controlling dollar spot. However,
reduced sensitivity to this class was first reported in Michigan and Ohio soon after (Golembiewski
et al., 1995). Many studies reported DMI resistance over the past two decades throughout the
United States (Bishop et al., 2008; Hsiang et al., 2007; Jo et al., 2006; Koch et al., 2009). Also,
Popko et al. 2012 reported the correlation of in vitro DMI fungicide insensitivity and field efficacy
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reduction of Clarireedia. spp. populations on New England golf courses (Popko et al., 2012).
DMIs being bound to the heme iron of CYP51 which is important in fungal sterol biosynthesis,
the resistance to DMIs is achieved through mutations in CYP51 genes (Hargrove et al., 2012;
Leroux et al., 2007). Also, overexpression of CYP51 by nucleotide changes in CYP51 promoter
(Luo and Schnabel, 2008) and gain-of-function mutations in transcription factors regulating
CYP51 has led to the development of resistance to DMIs (Dunkel et al., 2008). Lastly,
overexpression of ATP-binding cassette (ABC) and major facilitator superfamily (MSF) efflux
transporters has led to reduced sensitivity to DMIs (Cannon et al., 2009; De Waard et al., 2006;
Hulvey et al., 2012).

Xenobiotic detoxification in fungal organisms

Foreign chemical compounds found within living organisms are called xenobiotics and
these compounds include drugs, pollutants, pesticides, toxins, etc. (Misra et al., 2011). Eukaryotes
use specialized enzymes and pathways to metabolize xenobiotics and in general xenobiotic
detoxification involves phase I metabolism, phase II conjugation and phase III excretion
(Berenbaum and Johnson, 2015; Omiecinski et al., 2011). In phase I, enzymes modify the
xenobiotic compounds by oxidation, reduction, and hydrolysis reactions and the xenobiotics
become less toxic (Chen et al., 2012). Up to 75% of the phase I enzymes contain cytochrome P450s
(CYP450s) in human and most of the CYP450s are membrane bound in endoplasmic reticulum
(Chen et al., 2012; Guengerich, 2008). In phase II, phase I metabolites conjugate with endogenous
ligands mainly through methylation, esteration, acetylation, glucuronidation, sulfation and
glutathione and amino acid conjugation. After phase II, the conjugated metabolites are more
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hydrophilic than the phase I, therefore readily excreted at phase III which includes uptake or efflux
pumps (Chen et al., 2012).
ABC and MFS transporters are known to be associated with multidrug resistance in many
fungi that are agriculturally important (Cannon et al., 2009). For example, Candida albicans and
Candida glabrata azole resistant fungal strains showed reduced sensitivity to chemically different
fungicides through ABC transporter gene overexpression (Cannon et al., 2009). Phase I, II and III
enzymes and transporters that are induced in response to xenobiotics is regulated by transcription
factors. Nuclear receptor PXR (pregnane X receptor) upregulate transcription of Phase I (CYP3A
and CYP2B6), phase II (UGTs, GSTs, and SULTs superfamily), and phase III (P-gp and MRP2)
enzymes and transporters for detoxification by directly binding to the different xenobiotics
(Ihunnah et al., 2011). Constitutive androstane/activated receptor (CAR) is also a chemical sensing
transcription factor belonging to the orphan nuclear receptor superfamily and regulates phase I, II
and III enzymes and transporters. In human, these two nuclear receptors are known to involved in
developing multidrug resistance in various cancer cells. (Chen et al., 2012). Even if fungi do not
have nuclear receptor orthologous to ones in human based on the bioinformatic analysis, members
of the fungal zinc cluster transcription factors have sequence similarities with human nuclear
receptors (Näär and Thakur, 2009). Gain of function mutations in human and fungal zinc cluster
transcription factors cause constitutive overexpression of ABC transporters, resulting in increasing
resistance to the antifungal agents (Coste et al., 2006; Ferrari et al., 2009; Kretschmer et al., 2009).
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Discovery of a zinc-finger transcription factor associated with xenobiotic detoxification
genes harboring multidrug resistance in Clarireedia spp.

Mutations in zinc-cluster transcription factor pleiotropic drug resistance 1-Pdr1 (Zn2Cys6)
in Saccharomyces cerevisiae and Candida glabrata cause overexpression of ABC efflux
transporters, which leads to multidrug resistance upon fungicide treatments. Pdr1 binds to
chemically diverse xenobiotics and sustain the xenobiotic signaling by activating the expression
of efflux transporters (Thakur et al., 2008). These transporters include phase III secretion proteins
consisting ABC and other transmembrane efflux transporters (Ihunnah et al., 2011; Poulos, 2005;
Xu et al., 2005). However, not many studies are available about transcriptional regulation of
xenobiotic detoxification of filamentous fungi unlike ascomycete yeast and mammalian species.
In Clarireedia spp., ABC efflux transporters ShartrD and ShPDR1 were confirmed to have
effects on DMI resistance on Clarireedia field isolates (Hulvey et al., 2012; Sang et al., 2015). In
order to better understand transcriptional regulation of xenobiotic detoxification, high throughput
RNA sequencing of Clarireedia field isolates was conducted (Sang et al., 2018). Therefore, dollar
spot strains were collected from Hickory Ridge golf club (Amherst, MA) and biological samples
of fungicide-sensitive strains (HRS10) and multidrug-resistant (MDR) strains (HRI11) were
chosen for the RNA-seq study before and after treatment of 0.1µg/ml of propiconazole. The
HRS10 and HRI11 were found on a golf course fairway exhibiting a bimodal distribution where
resistant and sensitive subpopulations coexisted within the population, therefore experienced the
same conditions (i.e., same fungicide applications, same weather and same cultural practices).
They are more genetically related than a resistant isolate from Rhode Island and a sensitive isolate
from South Deerfield (Sang et al., 2015, 2018).
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From RNA-seq data, 209 genes were discovered from MDR strain which had significant
higher expression compared to the genes in sensitive strain. The 209 genes were clustered to three
groups based on the gene expression patterns. Group A has 13 genes showing constitutive
overexpression and includes three CYP450s (CYP561, CYP65 and CYP68), two ABC transporters
(ShPDR1, ShatrD), one lysophospholipase, one cellulose-binding protein, one carbohydrate
binding protein, one emopamil binding protein, and four hypothetical proteins. Group B also
contained 57 constitutively overexpressed genes in the MDR strain but no significant difference
in expression response to propiconazole in the sensitive strain. Group C contained 138 of
constitutively overexpressed genes but down regulated genes after exposure to the propiconazole
treatment (Figure 1).This group also contained xenobiotics detoxification related genes including
CYP450s, flavin-binding monooxygenases, one glutathione S-transferase and three MFS
transporters (Sang et al., 2018).
Overexpression of three phase I enzymes from group A in HRS10 fungicide-sensitive
strain developed increased level of resistance to propiconazole and flurprimidol compared to
HRS10. Also, overexpression of three CYP450s increased the biotransformation rate of
propiconazole (Sang et al., 2018). This biotransformation is probably because of the catalyzation
of propiconazole into its hydroxylated metabolite (Mazur et al., 2015). Phase III two transporters
from group A in HRS10 also showed reduced sensitivity to chemically different fungicides
compared to HRS10. These five genes in group A constitutively overexpressed in MDR resistant
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a)

b)

Figure 1: RNA-seq data analysis from fungicide sensitive strain and MDR strain (adapted from Sang et al.,
2018). a) Heat map generated from 4 treatments. Group A has 13 genes overexpressed, group B has 57 genes
overexpressed and group C has 138 genes overexpressed. b) 13 genes overexpressed in Group A, three CYP450s,
two ABC transporters, one Emopamil binding protein, one lysophospholipase, one cellulose-binding protein,
one carbohydrate binding protein, and four hypothetical proteins.

HRI11 strain and also induced by propiconazole, boscalid, flurprimidol and iprodione in both
HRS10 and HRI11 strains (Sang et al., 2015). Therefore, the overexpression of these three
CYP450s and two ABC transporters from group A led to develop multidrug resistant in both
multidrug sensitive and resistant strains of dollar spot by the phase I and III drug metabolism
pathways.
The upstream and the downstream sequence of three CYP450s and the two ABC
transporters in both HRS10 and HRI11 strains were identical. In order to find the genetic factor
behind the overexpression of these 5 genes, a probability variant detection analysis was conducted
between HRS10 and HRI11 for the 78 sequences of Zn2Cys6 transcription factors. One transcript
from HRI11 strain had an amino acid substitution from methionine (ATG) to threonine (ACG) at
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853rd codon (M853T). Therefore, the transcription factor was given a name as “xenobiotic
detoxification regulator 1 (XDR1)”. Sequencing of this gene in all drug sensitive (HRS10) and
MDR resistant (HRI11) strains used for this study proved the mutation present only in the MDR
resistant strain (Sang et al., 2018).
By generating XDR1 deletion and knockdown strains and xdr1 harboring T853M in HRI11
strain, XDR1 was confirmed to encode the transcription factor to overexpress three CYP genes
and two ABC transporters in MDR strain HRI11 as those mutants increased the sensitivity to
propiconazole, iprodione, boscalid and flurprimidol. Further to test whether the M853T is a
dominant or recessive gain of function mutation, HRS10 strain was transformed with 1500-bp
upstream and full length of XDR1 harboring M853T. The results indicated HRS10 (XDR1) mutant
gained multidrug resistance to chemically different fungicides similar to HRI11 strain and five
detoxification genes were constitutively upregulated. As conclusion, dominant gain of function
mutation M853T in XDR1 gene developed multidrug resistance in HRI11 strain (Sang et al.,
2018).
Human PXR nuclear receptor regulating CYP450s (specially CYP3A) is mechanistically
analogous to XDR1 in Clarireedia spp. which regulates CYP450s and ABC transporters (Kliewer
et al., 2002; Thakur et al., 2008). Also, Mazur et al. 2015 reported human CYP3A and Clarireedia.
spp. CYP450s are able to detoxify propiconazole. They also reported upregulation of CYP450s
and ABC transporters in both human and Clarireedia spp. happens by nuclear receptors of PXR
and XDR1 respectively to gain multidrug resistance (Mazur et al., 2015; Robbins and Chen, 2014;
Sang et al., 2018). This information about CYP450s, ABC transporters and nuclear transcription
factors- XDR1/PXR suggest that those are important key factors for xenobiotic detoxification and
also might evolved from early eukaryotes. Structurally unrelated transcription factors in human
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and fungi regulating detoxifying genes provide information to conclude eukaryotic drug
detoxification systems evolved convergently.
Identification of important protein domains of xdr1/XDR1 important to generate a
hypothesis to test the function of fungal transcription factor
Comparison with Pdr1 from S. cerevisiae and Tac1 from C. albicans revealed xdr1/XDR1
has two highly conserved domains (Figure 2). Cysteine-rich motif in the N-terminus of xdr1/XDR1
may possibly involve in Zn dependent DNA binding and part of the xenobiotic binding/activation
domain (XBD) which may have possible interactions with xenobiotics (Thakur et al., 2008).
Chromatin
immunoprecipitation
(ChIP)

using

hemagglutinin

(HA)

antibody experiments
proved DNA-binding
domain of xdr1/XDR1

Figure 2: Alignment comparison of amino acid sequences of DNA binding
domain and xenobiotic binding domain of xdr1 from Clarireedia spp., Tac1 from
C. albicans and Pdr1 from S. cerevisiae. Asterisks (*) represent identical amino
acids and colons (:) represent similar amino acids in the alignment.

indeed bound to the promoter region of PDR1 between -448 to -342 bp in HRS10 sensitive strain.
In addition, the study confirmed xdr1/XDR1 also binds to the promoter region of CYP561 between
-493 and -387 bp which also have a putative binding motif between -436 to -418 bp. Use of MEME
suite motif discovery tool reveled XDR1 is able to bind predicted DNA binding motifs in promoter
regions of three CYP450s and two ABC transporters in order to regulate xenobiotic detoxification
(Sang et al., 2018).
As a summary, a dominant gain-of-function mutation in XDR1 transcription factor in
Clarireedia spp. regulates constitutive overexpression of drug metabolizing genes responsible for
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multidrug resistance. Activation domain of Tac1 in azole resistant strain of C. albicans also have
a gain-of-function mutations (N972D, N997D and G980E) which are known to increase azole
resistance by up-regulating ABS transporters CDR1 and CDR2 (Coste et al., 2006; Sasse et al.,
2011). This similar study and the information from Thakur at al. (2008) support to predict the
M853T mutation may also locate in the transcription activation domain of XDR1 and regulate the
constitutive overexpression of CYP450s and ABC transporters. In addition, having an activation
mutation F815S in zinc cluster transcription factor Pdr1 in S. cerevisiae, it improves the occupancy
of co-activator complexes in the promoter region of PDR5 ABC transporter by altering the
promoter chromatin structure (Gao et al., 2004).
Due to a single amino acid substitution, XDR1 developed resistance to chemically different
fungicides and molecular analysis proved XDR1 also gained the ability to regulate constitutive
overexpression of drug metabolizing genes in the absence of fungicides (Sang et al., 2018).
Therefore, XDR1 may not bind with xenobiotics directly in order to regulate constitutive
overexpression and can be hypothesized that XDR1 can involve with other binding partners in
order to activate the transcription of drug metabolizing genes. If XDR1 binds to xenobiotics
directly, the constitutive overexpression cannot be explained. Those binding partners may function
as co-activator or a repressor in order to activate the transcription of CYP450s and ABC
transporters. As the M853T mutation located in the C-terminus of XDR1 that harbors the
transcriptional activation domain, the interaction between the XDR1 activation domain and the coactivator/repressor may affect by the mutation.
Thakur et al. (2008) reports activation domain in Pdr1 in S. cerevisiae interacts with the
KIX domain of gal11 coactivator to transcribe ABC transporters. Sang et al. (2018) studied and
identified a putative co-activator gal11 (TCONS_000105521) which contains gal11 co-activator
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domain. However, gal11 deletion mutants in HRI11 strain proved the identified putative gal11 has
no interactions with xdr1. Therefore, further experiments will be required to investigate the binding
partners of xdr1 and XDR1 which will activate the gene transcription in xenobiotic detoxification
pathway.
From a protein structure prediction software (I-TASSER), XDR1 protein structure was
predicted. From the protein transmembrane helices prediction tools (TMMHM: Transmembrane
Helices Hidden Markov Models and Phobius), one transmembrane domain was identified in
between the amino acids of 653 to 675 with a probability of more than 0.8. From the NCBI domain
search, transcription factor (TF) common domain and DNA binding domains were identified and
predicted in the XDR1 predicted model using I-TASSER (Figure 3 and 4).

Figure 3: TMMHM and Phobius models predicting a transmembrane domain in xdr1/XDR1. Blue color square in
the protein map represents the transmembrane domain. TMMHM has more than 0.8 probability between the amino
acids 653-675 and Phobius has probability of 1 in between the amino acids 656-675 predicting the transmembrane
domain.
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Figure 4: Predicted protein domains of xdr1/XDR1 transcription factor using I-TASSER.

Hypothesis of XDR1 drug metabolism mechanism and determination of protein-protein
interactions
Animal cells achieve Cholesterol balance through feedback regulation of Low-densitylipoproteins (LDL) receptors and regulation of enzymes in mevalonate synthesis. Sterols exercise
both transcriptional and post-translational control to degrade HMG-CoA reductase (3-hydroxy-3methyl-glutaryl-CoA) in endoplasmic reticulum (ER). LDR receptor transcription regulated by a
Sterol regulatory element 1 (SRE-1) depending on the cellular sterol level. SRE-1 have two
transcription factors-SREBP1 and SREBP-2, and 125 kD high molecular mass precursor of
SREBP-1 is bound to ER and the nuclear envelope. A study done in sterol-depleted HeLa cells
discovered a 68 kD fraction of SREBP-1 proteolytically cleaved and release to the nucleus from
ER membrane to enhance the transcription of SRE-1.
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Also,
transcription

another
family

NF-

kBI/Rel, important in innate
and

adaptive

immunity

follows a similar strategy of
extranuclear

confinement.

Cellular inactive forms of the
proteins

are

activated

by

multiple regulatory influences

Figure 5: Gasic (1994) established an ER membranal sterol
transcription factor mechanism (adapted from Gasic, 1994).

and transport to the nucleus
where DNA-binding site recognition, dimerization and nuclear localization occurred. However,
NF-kB/Rel is cloistered in cytoplasm where SREBP bound to the ER membrane. Also, NF-kB/Rel
known to activate by phosphorylation unlikely the SREBP-1 which is activated by the proteolytic
cleavage (Gasic, 1994) (Figure 5).
Depending on the studies done for transcription factor regulation, XDR1 transcription
factor mechanism is proposed. The inactive form of xdr1 may bound to ER membrane and a
binding partner (activator) bind to xdr1 activation domain. The xenobiotic molecule will bind to
the activator and will cleave from the activation domain of xdr1. This will activate the xdr1 and
the DNA-binding domain will proteolytically cleave from the ER bound xdr1 and will release into
the nucleus. In the nucleus, the DNA-binding domain may dimerize to bind with the promoter
region and initiate the transcription of phase I and III genes. In the MDR strain, the XDR1 having
the M853T mutation, the activator and the activation domain will have the low affinity to each
other compared to xdr1. Therefore, loose bound conformation of activator suggests the XDR1
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being pre-active for the xenobiotic binding. Therefore, when xenobiotic molecules bind to the
activator, the complex will leave the activation domain easily by cleaving the DNA-binding
domain. In this way, constitutive transcription proceeds to transcribe phase I and III genes to
regulate xenobiotic detoxification.
By finding the binding partners of xdr1/XDR1, our expectations are to find out new target
genes as new drug targets and also to better understand multidrug resistance mechanisms in
filamentous fungi. Furthermore, the results will be important to develop management strategies
for fungicide resistant field populations and ultimately would be beneficial for better management
of dollar spot in golf courses. This work will also provide foundation for studies conducted on the
other clinically and agriculturally important fungal pathogens which developed multidrug
resistance conferred by xenobiotic detoxification regulators.
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MATERIALS AND METHODS

Preparation of fungal protoplasts

The fungicide sensitive strain; HRS10 and fungicide resistant strain; HRI11 strains were
grown on potato dextrose agar (PDA) plates. Upon growth of mycelia on PDA plates, 5-7 agar
plugs (0.4 cm in diameter) were added to the flasks containing autoclaved potato dextrose broth
(PDB) media flasks and incubated at room temperature for four days with agitation. At optimal
mycelial growth, the hyphae were collected by filtering through four layers of sterile cheese cloth
through a funnel and washed with sterile water multiple times to remove excess media broth.
Hyphae were rinsed with protoplast buffer (0.8 M MgSO4. 7H2O, 0.2 M Sodium Citrate, at the
final pH 5.5) and the washed hyphae were chopped into smaller pieces using a sterile scalpel, and
transferred into a sterile Erlenmeyer flask containing 17 ml of protoplast buffer. A 200 mg of
Lysine enzymes from Trichoderma harzianum (Sigma-Aldrich, St. Louis) were dissolved in 3 ml
of Lysine enzyme buffer (1 M Sorbitol, 50 mM Sodium Citrate, 200 mg in 3 ml) and added the
mixture to each flask containing chopped hyphae and protoplast buffer. The flasks were incubated
at 28 ºC with a gentle agitation for 3 hours. The resulting protoplasts were filtered through sterile
cheesecloth to remove excess hyphal fragments and the solution was collected in a sterile
Erlenmeyer flask. A 30 ml of 0.6 M KCl was poured over the cheese cloth and collected in the
same flask. The protoplast solution was centrifuged in 50 ml centrifuge tubes at 3000 x g for 10
minutes at 4 ºC. The pelleted protoplast was washed twice with 10 ml of STC buffer (1 M Sorbitol,
50 mM Tris pH 8, 50 mM CaCl2. 2H2O). The protoplasts were counted using a Bright Line
Hemacytometer with 0.4-mm cover slip and then diluted with STC buffer to a final concentration
of 1x108 protoplasts/ml. Aliquots containing 500 µl of protoplast solution, 6.25 ul of DMSO, 31.25
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µl of Heparin (5mg/ml in STC buffer) and 125 µl of PEG solution (40% w/v PEG-4000, 0.6 M
KCl, 50 mM Tris pH 8, 50 mM CaCl2) were prepared and stored in -80 ºC freezer until further use
(Liu and Friesen, 2013).

DNA extraction from Clarireedia spp.

A 0.4 cm diameter fungal plug placed center of the PDA petri dish and grew for 4-5 days
until mycelia cover the 100% area of the petri dish. Mycelia collected (approximately 100 mg)
from surface of PDA plate using a pellet pestle and added to a 1.5 ml Eppendorf tube contains 400
µl extraction buffer (200 mM Tris-HCl pH 8, 200 mM NaCl, 30 mM EDTA and 0.5% SDS).
Mycelia grinded using the pellet pestle and incubated at 37 ºC for an hour. A 400 µl of CTAB
buffer (2% CTAB, 100 mM Tris-HCl pH 8, 20 mM EDTA, 1.4 M NaCl, 0.2% β-mercaptoethanol)
and 700 µl of Chloroform: isoamyl alcohol (24:1) were added to each tube and inverted to mix.
The tubes were centrifuged at 12000 rpm for 10 minutes and 600 µl of the supernatant was
transferred to a new tube. Equal amount of Chloroform: isoamyl alcohol (24:1) were added and
inverted to mix. The tubes were centrifuged at the same speed and duration, and 400ul of the
supernatant was transferred to another new tube. A 280 µl of isopropanol was added to the
supernatant and mixed well. The tubes were incubated for 10 minutes at room temperature and
centrifuged at 12000 rpm for 10 minutes. The DNA precipitate was washed with 500 µl of 70%
ethanol and centrifuged at 12000 rpm for 3 minutes to remove excess liquid from the precipitate.
The pellet was dried in room temperature for few hours and 200 µl nuclease free water was added
to dissolve the pellet. The DNA was quantified using the nanodrop spectrophotometer (Thermo
Scientific NanoDrop 2000) (protocol generated by Dr. Hyunkyu Sang, Jung lab, Stockbridge
School of Agriculture)
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Preparation of fungal transformants

The major objective of this project was to identify potential binding partners of the
xdr1/XDR1 transcription factor of Clarireedia spp. In order to accomplish this, xdr1/XDR1 DNA
sequences were tagged with a 3xFLAG tag (DYKDHDG-DYKDHDI-DYKDDDDK,
GACTACAAAGACCATGACGGTGATTATAAAGATCATGATATCGATTACAAGGATGA
CGATGACAAG) at the C-terminus. Protoplasts from sensitive HRS10 and resistant HRI11 were
then transformed with the resultant 3xFLAG-tagged xdr1/XDR1 DNA for a total of 4
transformants: HRS10-XDR1-3xFLAG, HRS10-xdr1-3xFLAG, HRI11-XDR1-3xFLAG and
HRI11-xdr1-3xFLAG. Initial experiments aimed to accomplish this transformation via
homologous recombination, but these methods were not successful. Instead, protoplasts were cotransfected with two constructs, one containing a 3xFLAG-tagged xdr1/XDR1 at the C-terminus
and the other containing a hygromycin resistant gene (HyGR) with its promoter, trpC.
To develop these constructs, a pYHN3 vector modified by Dr. Hyunkyu Sang (Jung lab,
Stockbridge School of Agriculture) was used to amplify the HyGR resistant gene and the trpC
promoter (1st construct). The 3xFLAG containing plasmid (pHS13) was received by Professor
Jae-Hyuk Yu (Bacteriology and genetics, University of Wisconsin-Madison). In order to prepare
the second construct, the pHS13 plasmid was cloned with xdr1/XDR1 gene with 1500 bp from its
upstream region (1500up+ xdr1/XDR1) and without the STOP codon of xdr1/XDR1. Therefore,
the 3xFLAG DNA sequence was inserted at the 3’ end of the construct. The 1500up+ xdr1/XDR1
amplicon was obtained by using two forward and reverse primers (just before the STOP codon) in
a PCR reaction with genomic DNA from HRS10 and HRI11 as the template (Q5 DNA Polymerase,
New England Biolabs, MA). The construct was confirmed by DNA sequencing (Psomagen Inc,
NY) and running 1% agarose gel stained with SYBRSAFE. In order to clone the construct to the
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Multiple Cloning Site (MCS), the primers were designed to add KpnI and NotI restriction sites
into the 5’ and 3’ ends of the 1500up+ xdr1/XDR1 construct respectively. After adding the
restriction sites by a PCR reaction, the PCR product was purified using a DNA clean and
concentrator kit (ZYMO research, CA) following the instructions (Lee et al. in preparation).
A 1 µg of 1500up+ xdr1/XDR1 construct with digestion ends was double digested at 37 ºC
for 1 hour using KpnI and NotI restriction enzymes (1 unit each), Cutsmart buffer (1X) (New
England Biolabs, MA) and nuclease free water to the final volume of 50 µl. The digested products
were purified using a DNA clean and concentrator kit (ZYMO research, CA) and quantified using
Nanodrop spectrophotometer (Thermo Scientific NanoDrop 2000). A 1 µg of pHS13 plasmid was
also digested using the same restriction enzymes, purified and quantified following the same
methods. The digested 1500up+ xdr1/XDR1 was ligated to the digested pHS13 plasmid using T4
ligase enzyme (New England Biolabs, MA) and cloned to DH5α competent cells following the
heat-shock transformation method. The colonies were picked following growth overnight on
Luria-Bertani (LB) agar plates at 37 ºC and grown in LB medium for overnight at 37 ºC with
agitation. The plasmids were extracted from the overnight grown E-coli culture using Zyppy
Plasmid Miniprep Kit (ZYMO Research, CA) and quantified using Nanodrop spectrophotometer
(Thermo Scientific NanoDrop 2000). Primers were designed to amplify the region starting from
1500up+ xdr1/XDR1 (Forward primer: F_1500upxdr1) to the end of FLAG sequence including
the STOP codon (Reverse primer: R_FLAG) from the extracted plasmids. A PCR reaction was
performed to amplify the above amplicon using Q5 DNA polymerase and confirmed by running a
1% agarose gel electrophoresis and sending for sequencing (Psomagen Inc, NY) (Lee et al. in
preparation).
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For the PEG mediated fungal transformation, the frozen protoplasts were thawed on ice. A
2 µg of the first construct containing trpC promoter with HygR was added to one vial of protoplasts.
To the same vial, 3 times molar amounts of the second construct (1500up+ xdr1/XDR1+3xFLAG)
was added. One protoplasts vial, containing an equal volume of STC buffer was maintained as a
negative control and added equal volume of STC buffer. The vials were incubated on ice for one
hour, 1 ml of PEG solution was added, and vials were incubated at room temperature for another
20 minutes. The protoplasts mixture was transferred to 15 ml falcon tubes and 5 ml of regeneration
media (1M sucrose, 0.1% yeast extract and 0.1% tryptone) was added. The falcon tubes were
incubated for 16 hours in a slanted position at room temperature with gentle agitation (150 rpm).
After incubation overnight, falcon tubes were centrifuged at 2500 g for 10 minutes at 4 ºC and the
pellet was resuspended in 200 µl of STC buffer. The resuspended protoplast mixture was spread
on regeneration medium agar (1 M sucrose, 0.1% yeast extract, 0.1% tryptone and 1.5% agar
(w/v)) containing 100 µg/ml of hygromycin B on 9-cm diameter petri dishes. No hygromycin-B
was added to the negative control. The plates were incubated at 25 ºC for 4-6 days to regenerate
the colonies. After fungal colonies appeared on regeneration agar media, the transformant colonies
were transferred to freshly prepared PDA plates containing 100 µg/ml of hygromycin B. The
transformants were repeatedly grown 4 times in hygromycin B amended PDA to ensure the
viability of transformants (modified protocols from Liu and Friesen. 2013) (Liu and Friesen,
2013).
The co-transfection facilitated random integration of xdr1/XDR1+3xFLAG to the
Clarireedia. spp. genome. The DNA fragment inserted to the genome of protoplasts were
confirmed by doing a PCR using the same primers (F_1500upxdr1 and R_FLAG) and using gDNA
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as the template. Successful transformants were confirmed by DNA sequencing and stored the
fungal plugs (0.9 mm in diameter) in 20% glycerol at -80 ºC until further use.

Real-time quantitative PCR (qRT-PCR) analysis
In order to test the expression level of 3xFLAG tagged xdr1/XDR1, a real-time PCR
analysis was done. The Actin (Shact) gene in Clarireedia spp. was selected as the housekeeping
gene with an amplicon size of 114 bp (Forward primer: 5’– TCGTGATTTGACCGATTACCTC–
3’, Tm= 57 ºC, Reverse primer: 5’– GCAACGTAA CAAACGTTCTCC– 3’, Tm= 56 ºC) (Sang
et al., 2018). The primers for the qPCR of 3xFLAG tagged transformants were designed manually
in a region where the mutation (M853T, ATG > ACG) found in the activation domain of the XDR1
with

an

amplicon

size

of

120

bp

(Forward

Primer:

F_xdr1AD:

5’–

CCAGCAACCATTTGTTCCAC – 3’, Tm: 58 ºC and the Reverse Primer: R_xdr1AD: 5’–
TCCGGGTCACCCACAATTC – 3’, Tm: 59 ºC).
To extract RNA from the fungal transformants, RNeasy Plant Minikit (Qiagen Inc.) was
used and followed the product information to extract RNA. The RNA was quantified using
nanodrop spectrophotometer (Thermo Scientific NanoDrop 2000). For the qPCR, Qiagen RotorGene Q qPCR machine was used with the Rotor-Gene SYBR Green PCR Kit and QuantiTect
Reverse Transcription Kit was used to perform the reverse transcription reactions. Quantitative
PCR reactions were performed in 25 μl reactions containing 12.5 μl of 2x Rotor- Gene SYBR
Green PCR Master Mix (Qiagen, Inc.), each primer to the final concentration of 1 uM, 1 μl of
cDNA from 250 ng/ μl dilutions, and nuclease free water to the final volume of 25 μl. PCR
conditions were as follows: initial activation step (1 cycle) for 5 minutes at 95 ºC and 40 cycles of
denaturation for 5 secs at 95 ºC, annealing for 10 secs at 60 ºC and extension for 30 secs at 72 ºC.
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The product protocol recommended to use 60 ºC as the annealing temperatures for all primers with
a Tm below 60 ºC. Relative quantification, 2−ΔΔCT method was used to calculate relative gene
expression (Livak and Schmittgen, 2001). The xdr1/XDR1 tagged with 3xFLAG tag were
considered as the treated conditions and non 3xFLAG tagged isolates (HRS10, HRI11) were
considered as the control. Three biological replicates and three technical replicates per each
biological replicate were performed for each fungal transformant. A student t-test was performed
on the analysis to find the significant relative mRNA expression in the transformants.

Preparation of whole cell lysate and coimmunoprecipitation
Four fungal transformants generated in the above experiments (HRS10-XDR1-3xFLAG,
HRS10-xdr1-3xFLAG,

HRI11-XDR1-3xFLAG

and

HRI11-xdr1-3xFLAG)

as

well

as

untransformed HRS10 and HRI11 as negative control were chosen for whole cell lysate extraction
and subsequent coimmunoprecipitation. Three biological replicates were grown for each of six
transformants/ control, for a total number of 18 samples for coimmunoprecipitation. The fungal
transformants were grown in 100 ml PDB media with gentle agitation for 4-5 days before the
cultures become discolored. Grown mycelia were filtered in a vacuum filter to remove excess
media and collected in a sterile filter paper (Whatman). After removing as much as media possible,
the mycelia were transferred to a pre-chilled mortar. The mycelia were grinding to a fine powder
and collected in 2ml screw cap tubes. The labeled tubes were stored in liquid nitrogen until all
samples were ground.
Based on protein modelling predictions, we hypothesize that xdr1/ XDR1 is a membranebound protein. In order to determine the optimal concentration of detergents necessary for
extracting XDR1/ xdr1 from cell membranes, lysis buffers (25mM Na-HEPES pH7.5, 75mM
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NaCl, 0.5mM EDTA, 10% glycerol, 1mM PMSF and one protease inhibitor tablet in 50 ml)
containing different detergents and combinations of detergents at various concentrations were
screened. Treatments of this screening included the following detergents/ concentrations: 2%
Triton X-100, 1% Triton X-100, 0.5% Triton X-100, 0.1% NP-40, 0.5% NP-40, 0.1% NP-40 with
0.5% Triton X-100, 2% Triton X-100 with 2% Tween 20 and finally 1% Triton X-100 with 0.1%
IGEPAL CA-630. Based on published data and the intensity of the western blot, 1% Triton X-100
was determined to be the optimal detergent for preparing whole cell lysates for
coimmunoprecipitation of xdr1/ XDR1.
A 500 µl of lysis buffer containing 1% Triton X-100 was added to each tube and incubated
for 1-2 hours at 4 ºC. The samples were centrifuged at the highest speed for 5 minutes at 4 ºC. The
supernatant was transferred to a prechilled new tube and 50 ul from the whole cell lysate was
transferred to new 1.5 ml microcentrifuge tubes. SDS-PAGE sample buffer was added at the final
concentration of 2X and heated at 95 ºC for 5 minutes. The prepared whole cell lysate samples
were saved later for SDS-PAGE analysis.
For coimmunoprecipitation, ANTI-FLAG M2 Affinity Agarose Gel (Sigma- Aldrich Co.
LLC) was used. The affinity gel was prepared according to the product instructions provided.
Briefly, the affinity gel beads were mixed using a cut regular pipette tip and 40 µl of 50% slurry
was transferred to the 1.5 ml microcentrifuge tubes. The beads were mixed with 500 µl TBS (50
mM Tris HCl, 150 mM NaCl, pH 7.4) and centrifuged for 30 seconds at 8000 x g. Supernatant
was removed and the washing step was repeated two more times. The tubes were placed on ice
until the whole cell lysate samples were ready. The 500-1100 µl of whole cell lysate was added to
each affinity gel beads tubes (total of 18) and incubated at 4 ºC for 1-2 hours with agitation. For
positive control 200 µg of FLAG-BAP fusion protein (Sigma- Aldrich Co. LLC) was used and as
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negative controls, HRS10 and HRI11 fungal strains were used. The samples were centrifuged for
30 seconds at 8000 x g and the supernatant was removed. The beads were washed with 500 µl of
TBS, vortexed, and centrifuged for 30 seconds at 8000 x g. The beads were washed two more
times. For the elution step, 2X SDS-PAGE sample buffer (125 mM Tris/HCl (pH 7.5 at 25 °C), 2
mM EDTA, 4% SDS, 0.02% bromophenol blue and 50% glycerol) was added to each bead
containing tubes and heated for 5 minutes at 95 ºC. The heated samples were centrifuged at
maximum speed for 3 minutes and the supernatant was transferred to a new 1.5 ml microcentrifuge
tube.
The whole cell lysate samples earlier stored and the eluted coimmunoprecipitated samples
were loaded into Mini-PROTEIN precast SDS-PAGE gels (Bio-Rad, CA) and ran with 1X SDS
running buffer (25 mM Tris, 192 mM Glycine, 0.1% SDS). The gel was run at 30 mA for about 2
cm below the bottom of the well (short-gel) and the gel was stained with Coomassie Brilliant Blue
G-250 (Thermo Fisher Scientific, MA). The stained gel was cut into pieces and collected into a
1.5 ml microcentrifuge tube containing 1 ml of sterile water. The SDS-PAGE gel pieces prepared
were submitted to UMass Medical School- Mass spectrometry facility for the proteomics analysis
for Nano LC-MS/MS using the Lumos orbitrap mass spectrometer.
The prepared whole cell lysate and coimmunoprecipitation samples were subjected to
western blotting in order to identify the FLAG tagged transformants. The protein samples were
run in SDS-PAGE gel as described above and western blot initiated by preparing PVDF membrane
by wetting it in methanol. The filter papers and sponges were soaked with 1x transfer buffer () and
the sandwich was assembled in a wet-transfer western blot apparatus (Bio-Rad, CA). The western
blot ran for 2 hours at 90 volts and the blots were blocked by 3% skim milk blocking buffer. The
primary antibody (Monoclonal ANTI-FLAG M2 antibody produced in mouse, Sigma-Aldrich)
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was prepared in the same blocking buffer at the concentration of 1:1000 and the secondary
antibody (Goat Anti-Rabbit (HRP), Abcam. Inc) was prepared at 1:2000 in the same blocking
buffer solution. After incubation with blocking buffer for one hour, the blots were washed with
TBS for 10 minutes and the washing step was repeated for 3 times. The blots were incubated with
primary antibody for overnight at 4 ºC and again washed with TBS for 3 times. The blots were
incubated with the secondary antibody for 1-2 hours at room temperature and washed as previously
described. The blots were visualized with Pierce ECL western blotting substrate (Thermo Fisher
Scientific, MA) according to the manufacture guidelines using a gel documentation system
(G:BOX mini Multi Fluorescence and Chemiluminescence imaging system, SYNGENE).

Sample preparation for Suspension-Trap (S-Trap) method
In this method, the SDS- containing protein lysates are processed in a minimum time with
minimum number of sample handling steps. The protein solution is lysed in 5% SDS followed by
adding phosphoric acid and methanolic buffer to prepare a fine protein particulate suspension. A
column with stack filtration material is used to trap the proteins in the solution and excess SDS
will be washed off. The proteins are digested within the filter material prior the analysis via LCMS/MS (Ludwig et al., 2018).
The 18 samples (three replicates each of six transformants) were processed at UMass
Worcester Medical School- Mass Spectrometry facility under the guidance of Prof. Scott Shaffer
and Dr. Nadia Sultana. The optimized protocol prepared by the facility members were used to
prepare the samples for S-Trap. The Co-IP samples were prepared as described above section in
2X SDS-PAGE sample buffer (125 mM Tris/HCl, pH 7.5 at 25°C), 2 mM EDTA, 4% SDS, 0.02%
bromophenol blue and 50% glycerol) eluted to the final volume of ~60 ul. The samples were
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vortexed and centrifuged at 4000 rpm for 3 minutes to collect the samples at the bottom. For
reduction, 1.6 ul of 38.8 mg/ml DTT were added to the samples and heated at 50 °C for 30 minutes
in a heat block. For alkylating disulfides, 1.6 ul of 92.6 mg/ml of IAA were added to every sample
and incubated for 30 minutes in the dark environment. After 30 minutes, 5.3 ul of 27.5% acidifierPhosphoric acid were added and the solution mix were transferred to the S-Trap Column (PROTIFI
S-Trap micro-MS sample prep kit ≥ 100 ug) 150 ul at a time. The columns were spined at 4000
rpm for 30 seconds. To trap proteins, 150 ul binding buffer (100 mM TEAB in 90% MeOH) was
added to the columns and centrifuged at the same speed and time. The washing with binding buffer
step was repeated for 5 times and at the 5th time, the columns were centrifuged for 2-3 minutes.
After the 5th wash, 25 ul of digestion buffer (4 ul of Trypsin stock mixed with 21 ul of 50 mM
TEAB) were added to each 18 columns to digest the proteins. The columns were incubated for
overnight at 37 °C. Next day, 40 ul of elution buffer 1 (30 mM TEAB in water) were added to the
columns and centrifuged for 1 minute at 4000 rpm. A 40 ul of elution buffer 2 (0.2% formic acid
in water) were added to the column and centrifuged at the same conditions. A 40 ul of elution
buffer 3 (50% acetonitrile) were added to the column and centrifuged at the same conditions. The
pooled elution solutions were collected to the pre-labeled 1.5 ml microcentrifuge tubes and placed
in -80 °C freezer for ~30 minutes following Speed Vac. The speed vac samples were reconstituted
with 5% acetonitrile, 0.1% formic acid. The samples were centrifuged at 16000 rpm for 16 minutes
and ran for LC-MS/MS.
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2. RESULTS AND DISCUSSION
Preparation of protein lysates and western blot analysis
The xdr1/XDR1 3xFLAG tagged fungal transformants were confirmed by PCR product
sequencing. For western blotting experiments to detect FLAG tagged xdr1/XDR1 proteins, it is
important to find the compatible detergent to add into the lysis buffer. For that, ANTI-FLAG M2
Affinity gel troubleshooting guide was referred (Sigma- Aldrich Co. LLC). According to the
product specifications, the compatible final concentrations of detergents in the lysis buffer are, 5%
or less Tween 20, 5% or less Triton X-100, 0.1% or less IGEPAL CA-630, 0.1% or less CHAPS,
0.2% or less Digitonin and 1.0 M or less sodium chloride. Depending on the trouble shooting guide
and published articles, many detergent combinations were screened. Of the total screened, four
combinations of detergents with specific concentrations successfully gave a signal in the western
blot (Figure 6). They are, 2% Triton X-100, 1% Triton X-100, 2% Triton X-100 with 2% Tween
20 and finally 1% Triton X-100 with 0.1% IGEPAL CA-630. For the western blot confirmation,
HRS10-XDR1-3xFLAG transformant was used

kDa

because this transformant always gave a strong
130
100

signal in the western blot trials.
According to the western blotting results,
the lysis buffer used with 1% Triton X-100 gave
better signals in western blotting images. Even if
the 2% Triton X-100 gave better signals, we
decided to use 1% Triton X-100 because the coimmunoprecipitation

protocols

recommended

using the lowest possible detergent concentration.
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Figure 6: Western blotting image of whole cell lysate
of HRS10-XDR1-3xFLAG transformant with
detergents in lysis buffer: 1) 2% Triton X-100, 2) 1%
Triton X-100, 3) 2% Triton X-100 and 2% Tween20,
4) 1% Triton X-100 and 0.1% IGEPAL CA-630. An
8% SDS-PAGE was used. Primary antibody was
monoclonal ANTI-FLAG M2 antibody produced in
mouse (1:1000) and the secondary antibody was Goat
Anti-Rabbit (HRP) (1:2000). Around 200-300 mg of
proteins were loaded to each gel. The molecular
marker indicated at left in kDa. The expected size of
the signal is 119 kDa.

However only the HRS10-XDR1-3xFLAG gave an expected signal size of 119 kDa in the western
blot and other three transformants, HRS10-xdr1-3xFLAG, HRI11-XDR1-3xFLAG and HRI11xdr1-3xFLAG, did not give significant signals in western blots even with higher detergent
concentrations. Using the 1% Triton X-100 in lysis buffer, the whole cell lysate was collected from
all six samples and ran in a western blot (input). According to the western blot images, only
HRS10-XDR1-3xFLAG gave a signal in both input and co-immunoprecipitated samples (Figures
7 and 8).
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Figure 7: Coimmunoprecipitated fungal transformants. Only HRS10-XDR1-3xFLAG has a significant signal at
expected size of 119 kDa. 1) HRS10, 2) and 3) HRS10-XDR1-3xFLAG, 4) HRS10-xdr1-3xFLAG, 5) HRI11, 6)
HRI11-XDR1-3xFLAG, and 7) HRI11-xdr1-3xFLAG. An 8% SDS-PAGE gel was used for the western blot wet
transferring. Primary antibody was monoclonal ANTI-FLAG M2 antibody produced in mouse (1:1000) and the
secondary antibody was Goat Anti-Rabbit (HRP) (1:2000). Around 200-300 mg of proteins were loaded to each gel.
The molecular marker indicated at left in kDa.

However, in order to see whether other two FLAG tagged transformants give any western
blotting signal in the presence of propiconazole, 0.1 ppm of propiconazole added to the 4-days old
growing mycelia and incubated for 30 minutes. After 30 minutes’ incubation, the whole cell lysates
were extracted and run in a western blot. No signals for FLAG tagged xdr1/XDR1 were detected
except for the HRS10-XDR1-3xFLAG and HRS10-xdr1-3xFLAG (Figure 9).
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3xFLAG signal was slightly detected in
the western blot. According to the
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previous western blot trials, this signal
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was appearing even without adding

70

propiconazole.
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The

Co-IP

samples

prepared for LC-MS/MS analysis were

Figure 8: Input western blot image for transformants 1)
HRS10, 2) HRI11, 3) HRS10-XDR1-3xFLAG, 4) HRS10xdr1-3xFLAG, 5) HRI11-XDR1-3xFLAG, and 6) HRI11xdr1-3xFLAG. An 8% SDS-PAGE gel was used for the
western blot wet transferring. Primary antibody was
monoclonal ANTI-FLAG M2 antibody produced in mouse
(1:1000) and the secondary antibody was Goat Anti-Rabbit
(HRP) (1:2000). Around 200-300 mg of proteins were
loaded to each gel. The molecular marker indicated at left
in kDa. Expected size of the signal is 119 kDa.
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not detected with a signal of particular
that sample. Therefore, without further
confirmation experiments, it’s difficult to
come into a solid conclusion.
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Figure 9: Input western blot image for the fungal transformants when
incubated with 0.1 ppm propiconazole for 30 minutes. 1) HRS10, 2)
HRI11, 3) HRS10-XDR1-3xFLAG, 4) HRS10-xdr1-3xFLAG, 5)
HRI11-XDR1-3xFLAG, and 6) HRI11-xdr1-3xFLAG. An 8% SDSPAGE gel was used for the western blot wet transferring. Primary
antibody was monoclonal ANTI-FLAG M2 antibody produced in
mouse (1:1000) and the secondary antibody was Goat Anti-Rabbit
(HRP) (1:2000). Around 200-300 mg of proteins were loaded to each
gel. The molecular marker indicated at left in kDa. The expected size
of the signal is 119 kDa.
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Testing level of mRNA expression in transformants using qRT-PCR
In order to test the mRNA expression of the transformants, qRT-PCR analysis was
performed. Therefore, the objective was to test whether the FLAG tagged xdr1/XDR1 proteins
produce significant amount of mRNA to produce particular recombinant proteins. The student ttest was performed to test the significant mRNA level expression. The summarized data for the
qRT-PCR was shown in the Figure 10. Even if all four of FLAG tagged transformants showed
mRNA expression compared to the control (HRS10 and HRI11), only HRS10-XDR1-3xFLAG
transformant had a statistically significant expression levels of mRNAs compared to the control
HRS10 (p-value is 0.0059 at 0.01 significance level).
(a)

(b)
**

Figure 10: Relative mRNA expression levels of FLAG tagged transformants compared to the controls (HRS10
and HRI11). The p-values at 0.01 significance level as follows: (a) HRS10= 1, HRS10-XDR1-3xFLAG=
0.0059 and HRS10-xdr1-3xFLAG= 0.2337 (b) HRI11= 1, HRI11-XDR1-3xFLAG= 0.3572, and HRI11-xdr13xFLAG= 0.7519. ** p < 0.01.

These results indicate that only HRS10-XDR1-3xFLAG has significant mRNA level
expression and other three FLAG transformants are not statistically significant at the 0.01
significance level. These results support the Co-IP and input western blot images as only HRS10-
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XDR1-3xFLAG gave a significant signal in the western blots. Therefore, the relative mRNA level
expression of HRS10-XDR1-3xFLAG is compatible with the results obtained for western blots of
HRS10-XDR1-3xFLAG. However, the HRS10-xdr1-3xFLAG also detected in mass spectrometry
data when used the S-Trap method for proteomics analysis. Therefore, the qPCR results obtained
for HRS10-xdr1-3xFLAG does not compatible with the western blot images obtained for HRS10xdr1-3xFLAG.

Summary of LC-MS/MS data analysis of co-immunoprecipitation
Even all FLAG tagged transformants didn’t give signals in the western blots, we decided
to send all four FLAG tagged co-IP samples with two negative controls for Nano-LC/MS-MS for
further analyzing for finding out binding partners of xdr1/XDR1. Therefore, three biological
replicates (18 in total) of each fungal transformants with HRS10 and HRI11 were sent to the Mass
spectrometric facility for further analysis (University of Massachusetts Medical School, Worcester
MA). Protein database prepared using the genomic sequencing data of HRS10 and HRI11 were
used for the database search (Shi et al. in preparation). The HRI11 database has more proteins
annotated compared to the HRS10. The summarized information of the two databases for HRS10
and HRI11 were shown in the Table 1.
Table 1: Summarized information of HRS10 and HRI11 genomic assembled databases used for
the LC-MS/MS database search (Shi et al. in preparation).
Assembly Feature

Clarireedia spp. strain
HRS10

HRI11

Number of Scaffolds

101

52

N50 Scaffold length (Mb)

1.4

1.6

Largest Scaffold (Mb)

3.2

4.1
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Assembly Length (Mb)

39.6

43.6

Repeat content of assembly (%)

9.07

11.63

Number of predicted proteins

12,185

12,869

GC content of Genes (%)

43.57

41.72

Integrity of assembly (%)

98.6

98.5

Integrity of transcriptome (%)

98.1

98.0

Number of proteins classified into COGs

9270

9618

Since the Clarireedia spp. is not a model organism unlike the most other species, the
information available for data annotation and GO terms (Gene Ontology) is limited. Not all the
proteins in the database we used were annotated or have GO terms and most are hypothetical or
unknown. However, the protein database was categorized using the Clustered Orthologous Groups
(COGs) and the proteins were characterized based on their function.
According to the NCBI COGs database (https://www.ncbi.nlm.nih.gov/research/cog),
there are 26 COG categories (Table 2). The initial COG database prepared in 2000 used proteins
encoded in 21 complete genomes of bacteria, archaea and eukaryotes (Tatusov et al., 2000). The
database included 56-83% from complete genomes of bacteria and archaea and ~35% from
complete genome of S. cerevisiae. In 2003, the number of prokaryotic genomes increased to 43 in
the COGs and ~60 to ~85% of prokaryotic encoded proteins were included in the COGs (Tatusov
et al., 2003). Currently, the database includes complete genomes of 1187 bacteria and 122 archaea
(Galperin et al., 2021). However, COG system further extended to include complex and
multicellular eukaryotes of animals, fungi, microsporidia and plants with complete genomes and
named eukaryotic orthologous groups (KOGs) (Tatusov et al., 2003).
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Table 2: NCBI published COGs classification.
COG

COGs Classification

COG

Category

COGs Classification

Category

A

RNA processing and modification

N

Cell motility

B

Chromatin structure and dynamics

O

Posttranslational modification,
protein turnover, chaperones

C

Energy production and conversion

P

Inorganic ion transport and
metabolism

D

Cell cycle control, cell division, chromosome

Q

partitioning

Secondary metabolites biosynthesis,
transport and catabolism

E

Amino acid transport and metabolism

R

General function prediction only

F

Nucleotide transport and metabolism

S

Function unknown

G

Carbohydrate transport and metabolism

T

Signal transduction mechanisms

H

Coenzyme transport and metabolism

U

Intracellular trafficking, secretion,
and vascular transport

I

Lipid transport and metabolism

V

Defense mechanisms

J

Translation, ribosomal structure and biogenesis

W

Extracellular structures

K

Transcription

X

Mobilome: prophages, transposons

L

Replication, recombination and repair

Y

Nuclear Structure

M

Cell wall/membrane/envelope biogenesis

Z

Cytoskeleton

All MS/MS samples were analyzed using Mascot (Matrix Science, London, UK; version
Mascot in Proteome Discoverer 2.1.1.21). Mascot was searched with a fragment ion mass tolerance
of 0.050 Da and a parent ion tolerance of 10.0 PPM. For the criteria for protein identification,
Scaffold viewer (version Scaffold_4.11.1, Proteome Software Inc., Portland, OR) was used to
validate MS/MS based peptide and protein identifications. Peptide identifications were accepted
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if they could be established at greater than 88.0% probability by the Peptide Prophet algorithm
with Scaffold delta-mass correction. Protein identifications were accepted if they could be
established at greater than 99.0% probability and contained at least 2 identified peptides. Proteins
that contained similar peptides and could not be differentiated based on MS/MS analysis alone
were grouped to satisfy the principles of parsimony. Proteins sharing significant peptide evidence
were grouped into clusters.
The proteins identified in the scaffold viewer software were grouped according to the NCBI
COGs classification to identify protein groups that had possible interactions with XDR1 protein.
The summarized number of proteins detected in all three replicates of each sample were shown
below in a Venn diagram (Figure 11).

a)

b)

HRI11

1
10

137

206

76

253

HRI11-XDR1-3xFLAG

31

369

4
26

HRS10-XDR1-3xFLAG

HRS10-xdr1-3xFLAG
HRI11-xdr1-3xFLAG

Figure 11: Venn diagram summarizing the number of proteins detected in each transformants. a) The number of proteins detected
for HRS10 transformants. HRS10 data is missing due to a technical difficulty occurred during LC-MS/MS analysis. b) The
number of proteins detected for HRI11 transformants.

According to the data obtained from Scaffold viewer software, common proteins detected
among the three biological samples of each transformants were recorded in the Venn diagram.
Unfortunately, upon processing for LC-MS/MS, three biological replicates of HRS10 were lost
due to technical problems associated with sample preparation (Figure 11a). Therefore, further data
analysis was performed without the data generated from HRS10. The proteins in the Venn
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diagrams were grouped according to the COGs classification systems. The summarized
information is shown in the Figure 12-15.

HRI11-XDR1-3xFLAG
743 CANDIDATES

HRS10-XDR1-3xFLAG
263 CANDIDATES

Figure 12: Protein candidate comparison between the groups of HRS10-XDR1-3xFLAG and HRI11-XDR1-3xFLAG.
The number of proteins is classified according to the COGs classification. Most of the proteins are included in J
(Translation, ribosomal structure and biogenesis), O (Posttranslational modification, protein turnover, chaperones) and
S (function unknown) categories. A 227 proteins are sequentially identical between the two groups.

HRS10-xdr1-3xFLAG
328 CANDIDATES

HRI11-xdr1-3xFLAG
605 CANDIDATES

Figure 13: Protein candidate comparison between the groups of HRS10-xdr1-3xFLAG and HRI11-XDR13xFLAG. The number of proteins is classified according to the COGs classification. Most of the proteins are
included in J (Translation, ribosomal structure and biogenesis), O (Posttranslational modification, protein turnover,
chaperones) and S (function unknown) categories. A 270 proteins are sequentially identical between the two
groups.
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HRS10-XDR1-3xFLAG and
HRS10-xdr1-3xFLAG

Figure 14: Protein candidate comparison between HRS10-XDR1-3xFLAG and HRS10-xdr1-3xFLAG. A 293 protein
candidates are sequentially identical. Most of the proteins are included in J (Translation, ribosomal structure and
biogenesis), O (Posttranslational modification, protein turnover, chaperones), S (function unknown), and C (energy
production and conversion) categories.

HRI11-XDR1-3xFLAG and
HRI11-xdr1-3xFLAG

Figure 15: Protein candidate comparison between HRI11-XDR1-3xFLAG and HRI11-xdr1-3xFLAG. A 566 protein
candidates are sequentially identical. Most of the proteins are included in J (Translation, ribosomal structure and
biogenesis), O (Posttranslational modification, protein turnover, chaperones), S (function unknown), and C (energy
production and conversion) categories.
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The total number of COGs classification includes 26 protein categories. Out of 26
categories, the detected proteins were belonged among 22 COGs categories. Majority of the
protein candidates were included in J: Translation, ribosomal structure and biogenesis category,
O: Posttranslational modification, protein turnover, chaperones category, S: Function unknown,
C: Energy production and conversion, U: intracellular trafficking, secretion and vascular transport
and E: Amino acid transport and metabolism. The COGs groups that didn’t identified upon the
analysis were N: Cell motility, W: Extracellular structures, X: Mobilome, prophages and
transposons, and N: General function prediction only.
However, only one biological replicate of HRS10-XDR1-3xFLAG detected with the
XDR1 protein (Accession number FUG_008883-T1) and that protein is associated with 9 other
protein candidates (Figure 16b). Therefore, we believe these nine candidates are directly associated
with the XDR1 protein and further identification and sequence analysis were performed using the
database and NCBI protein blast search. HRI11 did not detected with xdr1/XDR1 protein in any
of the three replicates (Figure 16a).
The amino acids sequences of the nine candidate proteins were searched in the NCBI
protein blast. The sequences were most identical with the Rutstroemia sp., one of the closest related
species as Clarireedia spp. and the function of most candidates were annotated. The summarized
information is shown in the Table 3.
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(a)

(b)

Figure 16: The XDR1 protein detection in the Scaffold viewer software. (a) HRI11 transformants were not detected with
XDR1 in any of the replicate. (b) A one biological replicate of HRS10-XDR1-3xFLAG were detected with XDR1, and it
represents with the accession number of FUG_008883-T1 (arrow to the right in the table and arrow shown in the normalized
spectra)

Table 3: Protein Blast result of the nine protein candidates detected with XDR1 in HRS10-XDR13xFLAG transformant in LC-MS/MS data.

Accession Number

Sequence coverage

Size of the

detected in the

peptide

Scaffold Viewer (%)

(kDa)

14

28

Description according to the

Percentage

Rutstroemia sp.

identity (%)

Centromere microtubule-binding Cbf5
FUG_002724-T1

89
protein

FUG_003814-T1

11

48

Legume-like lectin protein

97

FUG_009233-T1

7

30

Hypothetical Protein

89

FUG_004773-T1

6

38

Homo-isocitrate dehydrogenase protein

99

37

Dihydrolipoamide acetyltransferase
FUG_000189-T1

28

18

component of pyruvate dehydrogenase

98

protein
Mitochondrial 2-oxodicarboxylate
FUG_008404-T1

7

33

94
carrier protein

FUG_010028-T1

6

54

Delta (14)-sterol reductase protein

98

FUG_000263-T1

2

119

Putative calcium-transporting ATPase

99

FUG_004358-T1

1

45

Hypothetical protein

99

According to the protein blast, all nine candidates in Clarireedia spp. have more than 89%
of percentage identity with the Rutstroemia sp. The sequence coverage detected in the mass
spectrometry is also lower and detected in only one biological replicate. Therefore, it’s impossible
to come into any conclusion with these data which was observed in only one biological replicate.
Therefore, after a lengthy discussion with the expertise at the Mass spectrometry facility of UMass
Medical School, the samples were prepared for the LC-MS/MS again, but the Suspention-Trap (Strap) method was used to prepare the samples for LC-MS/MS.
The efficient protein digestion into the peptides is important for proteomics and LCMS/MS based detection. Most abundant methods are the use of in-solution and filter-based
methods for protein digestion. However, the use of filter-aided sample preparation (FASP) method
known to be the most successful method for proteomics analysis, as the excess SDS will be
removed prior the mass spec analysis. But the time required for the sample preparation based on
FASP method is higher compared to the in-solution and filter-based methods. Therefore,
Suspension-Trap method was developed as a solution for both in-solution and FASP proteomics
analysis methods. The S-Trap method reported higher yield of unique peptides identification in
mass spectrometry analysis compared to the in-solution and FASP methods with higher
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reproducibility. Also, the time taken to prepare S-Trap proteomics samples are less compared to
the FASP method and S-Trap method is compatible to use with higher SDS concentrations in the
samples (Ludwig et al., 2018). Therefore, moving forward with S-Trap method was the best option
we had compared to repeating the analysis with the in-solution digestion method.

Identification of protein binding partners of XDR1 with the S-Trap based LC-MS/MS
The scaffold viewer file for the S-trap processed LC-MS/MS data detected XDR1 protein
over two out of three biological replicates in the transformants of HRS10-XDR1-3xFLAG. There
are 54 associated proteins with the XDR1, which are summarized in Figure 17 and Table 4. Most
of these associated proteins were detected in more than two biological replicates. The xdr1/XDR
proteins were not detected in any of the HRI11 FLAG tagged transformants.
(b)

(a)

Figure 17: The XDR1 protein detection in the Scaffold viewer software. (a) HRI11 transformants were not detected
with XDR1. (b) Two biological replicates of HRS10-XDR1-3xFLAG were detected with XDR1. It represents with the
accession number of FUG_008883-T1 (arrow to the right in the table and arrows shown in the normalized spectra).
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Table 4: The summarized information of protein candidates detected in LC-MS/MS when STrap method used to prepare the samples.
Sequence
Size of
coverage
Accession
Number

the

Description according to

Percentage

COGs

peptide

the Rutstroemia sp.

identity (%)

Category

89.7

Q

95.2

I

94.5

C

84.1

E

95.08

O

71.8

G

detected in the
Number
Scaffold
(kDa)
Viewer (%)
FUG_006095-

1

Alcohol dehydrogenase
29

41

T1

protein

FUG_0060902

NRPS-like enzyme
25

116

T1

protein
Short chain

FUG_0060913

38

39

dehydrogenase reductase

T1
protein
Glucose-methanolFUG_0060934

2

67

choline oxidoreductase

T1
protein
FUG_0045445

Disulfide-isomerase
10

39

T1

erp38 protein

FUG_0003816

Cell wall glucanase
2

48

T1

protein

FUG_0101807

26

23

Hypothetical protein

67.5

S

34

14

Hypothetical protein

81.8

S

1

177

N/A

N/A

N/A

T1
FUG_0043628
T1
FUG_0021839
T1

40

Eukaryotic translation
10

FUG_0036348

28

initiation factor 3 subunit

98.4

J

96

A

93.6

J

84.7

S

91.6

I

98.23

U

92.5

O

89.9

N/A

91.8

O

T1
K protein
FUG_00059911

RNA recognition domain8

19

T1

containing protein

FUG_01107812

1

68

17

22

Hypothetical protein

T1
FUG_00122813

Malate dehydrogenase

T1

protein

FUG_00702914

Polyubiquitin binding
2

83

T1

protein
Mitochondrial import

FUG_00122915

3

68

receptor subunit tom-70

T1
protein
FUG_00626916

Cytochrome c oxidase
2

54

T1

assembly cox15 protein

FUG_00210717

Pentatricopeptide repeat
12

41

T1

protein

FUG_00549318

Tripeptidyl-peptidase 1
6

68

T1

precursor protein

FUG_00497719

17

42

Hypothetical protein

82.5

S

19

28

Hypothetical protein

86

S

13

26

88.3

P

T1
FUG_00706920
T1
FUG_00948421

Carbonic anhydrase

T1

protein

41

Mitochondrial inner
FUG_00295022

03

60

membrane translocate

94.8

U

91.6

E

89.8

O

94.9

P

T1
subunit TIM44 protein
Glucose-methanolFUG_00198523

01

149

choline oxidoreductase

T1
protein
FUG_00995724

Glutathione S-transferase
07

29

T1

protein
Heavy-metal-associated

FUG_00235725

50

10

domain-containing

T1
protein
FUG_01178026

02

120

Hypothetical protein

96

A

06

64

Putative laccase-2 protein

91.8

Q

14

28

Zinc knuckle protein

96.3

O

05

47

Hypothetical protein

94.7

O

06

119

91.9

I, U

95.5

S

94.7

F

T1
FUG_00324127
T1
FUG_00324628
T1
FUG_00104329
T1
FUG_00900630

DDHD-domain

T1

containing protein

FUG_00989631

DUF1295 domain03

40

T1

containing protein
Uracil

FUG_00269132

04

27

phosphoribosyltransferase

T1
protein

42

FUG_01139933

12

41

DUF967 domain protein

69.9

S

01

184

N/A

N/A

N/A

05

31

Hypothetical protein

96.1

U

93.3

I

N/A

C

98

Q

86.4

E

96.1

O

97.8

E

T1
FUG_00662434
T1
FUG_00219035
T1
Phospatidylethanolamine
FUG_00026636

01

114

N-meth-yltransferase

T2
protein
FUG_01028037

07

45

09

37

N/A

T1
FUG_00714738

Short chain

T1

dehydrogenase protein

FUG_00288539

Zinc carboxypeptidase
05

45

T1

protein

FUG_00584940

Peptide methionine
20

23

T1

sulfoxide protein

FUG_00893441

Dihydroxy-acid
06

64

T1

dehydratase protein

FUG_00901342

13

36

Ost3 Ost6 family protein

94.2

O

16

23

Hypothetical protein

90.8

S

75.5

S

T1
FUG_00101443
T1
Glutathione-dependent
FUG_00610644

13

19

formaldehyde-activating

T1
GFA protein

43

FUG_00714945

SH3 domain containing
05

42

T1

94.4

S

45.2

Q

protein
Short-chain

FUG_00175046

11

27

dehydrogenase reductase

T1
SDR protein
FUG_00258347

26

15

STF2 protein

92.2

N/A

07

37

SMC domain protein

78

S

13

16

N/A

N/A

T

05

44

Hypothetical protein

87.8

S

96.7

D

75.4

N/A

92.4

U

97.1

T

T1
FUG_00347548
T1
FUG_00574849
T1
FUG_00906650
T1
Nuclear condensin
FUG_00366451

02

158

complex subunit smc4

T1
protein
FUG_00100752

Fucose-specific lectin
10

33

T1

protein

FUG_00256253

Msp domain-containing
15

32

T1

protein

FUG_01167554

DENN-domain
02

123

T1

containing protein

N/A: Data not available

The 54 candidates detected interactions with XDR1 in HRS10-XDR1-3xFLAG were
categorized based on the COGs classification. The summarized group information shown in the
Figure 18.
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Figure 18: COGs classification for the 54 XDR1 binding partners from S-Trap analysis.

According to the COGs classification, most of the binding partners belong to the post
translational modification, protein turnover, and chaperones (O) group and the intracellular
trafficking, secretion, and vascular transport (U) group. Having transcription factor binding sites
and domains in XDR1, these data prove that most of the XDR1 binding partners have
characteristics related to DNA transcription as expected.
By observing the types or families of the proteins detected in mass spectrometry, our
hypothesis can be supported, modify or rejected with these binding partners. Using the published
articles related to some selected binding partners mentioned above with drug metabolism, a
summary of explanation below is provided for the future use of these results.
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The binding partners detected included dehydrogenases family proteins. Dehydrogenases
are important to catalyze the oxidation and reduction reactions with coenzymes. Dehydrogenases
collaborate with aldo-keto-reductases (AKRs) and cytochrome P450s in metabolic pathways.
AKRs are known to detoxify aldehydes and ketones that generate during the metabolization of
xenobiotics like drugs and toxins in human (Barski et al., 2008). Even though not much
information is available for dehydrogenases of fungal species, they may have a role in oxidation
or reduction in the activation domain to produce metabolites like aldehydes and ketones.
Conformational and pH changes may cause changes in activation domain and enhance the
cleavages which result the DNA binding domain migration to the nucleus.
Similar to dehydrogenases, oxidoreductases are also one of transfer electrons catalyzing
the oxidation reactions with the use of cofactors. Transmembrane oxidoreductase proteins make
electron transport chains in respiration in both eukaryotic and prokaryotic species. Cytochrome
P450 oxidoreductases are known to catalyze the reactions for drug metabolism and steroid
hormones metabolism in human (Pandey and Sproll, 2014). It would be interesting to test the
relationship of detected oxidoreductases with XDR1 as if they were also transmembrane proteins,
then we will be able to further modify our hypothesis identifying possible electron transport
pathway (s).
Among the detected proteins, glutathione-S-transferases (GSTs) are interesting since they
are very well known in phase II drug metabolism pathways, as they conjugate with xenobiotics to
reduce the drugs’ toxicity. GSTs can bind with broad range of ligands which are mostly
electrophilic compounds and subsequently excreted by the phase III efflux pump proteins.
Ascomycetes and basidiomycetes have higher complexity of GSTs that are capable of degrading
varieties of organic compounds (Morel et al., 2009). The glucose-methanol-choline (GMC) is a
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superfamily belonging to the family of oxidoreductases. Fungal GMCs are very known for
lignocellulose degradation, aryl-alcohol oxidoreduction, glucose oxidation and many other
oxidation and reduction pathways. GMCs are found in filamentous fungi, yeasts, bacteria and,
insects (Sützl et al., 2019).
11 unique peptides among the 54 candidate proteins were selected based on the abundance.
These unique peptides are summarized in the Table 5 and all 11 candidates were present at least
two biological replicates among the three. These 11 unique peptides belong to eight different
COGs groups and had more than 80% of sequence similarity with the Rutstroemia sp. according
to the NCBI Blast search.
Table 5: Most abundant unique peptides among 54 candidates which present more than 2
biological replicates among 3 totals.
Sequence coverage

Detection in

Size of the

detected in the

biological

peptide

Scaffold V4 (%)

replicates

(kDa)

29

3/3

41

Accession
Number

FUG_006095-

Description according to

COGs

the Rutstroemia sp.

Category

Alcohol dehydrogenase

T1

Q
protein

FUG_00609025

2/3

116

38

2/3

39

NRPS-like enzyme protein

I

T1
FUG_006091-

Short chain dehydrogenase

T1

C
reductase protein

FUG_004544-

Disulfide-isomerase erp38
10

2/3

39

T1

O
protein

FUG_002107-

Pentatricopeptide repeat
12

3/3

41

T1

N/A
protein
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FUG_00948413

2/3

26

50

2/3

10

Carbonic anhydrase protein

P

T1
FUG_002357-

Heavy-metal-associated

T1

P
domain-containing protein

FUG_00324614

3/3

28

9

2/3

37

Zinc knuckle protein

O

T1
FUG_007147-

Short chain dehydrogenase

T1

Q
protein
Eukaryotic translation

FUG_0036348

3/3

28

initiation factor 3 subunit

J

T1
K protein
FUG_000599-

RNA recognition domain8

3/3

19

T1

A
containing protein

N/A: Data not available

Apart from the most abundant unique peptides, the peptides belong to the COGs “S”
category (function unknown) were also chosen and summarized in the Table 6. The sequence of
each unique peptide was blasted using NCBI database and identified most sequentially similar
description based on Rutstroemia sp. Most of the peptides were hypothetical proteins and some
peptides were identified with a function/protein name. Not all these peptides were available in all
biological replicates and most were detected only in one biological replicate among the three.
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Table 6: The unique peptides available in function unknown (S) group.
Detection in
Sequence Coverage
Accession

Size of the
out of 3

detected in the
Number

Description according to the

COGs

Rutstroemia sp. (% similarity)

Group

peptide
Biological

Scaffold Viewer (%)

(kDa)
replicates

FUG_01018026

3/3

23

Hypothetical protein

S

34

1/3

14

Hypothetical protein

S

17

3/3

22

T1
FUG_004362T1
FUG_001228-

Malate dehydrogenase protein

T1

S
(84.7%)

FUG_00497717

2/3

42

Hypothetical protein

S

19

1/3

28

Hypothetical protein

S

3

1/3

40

T1
FUG_007069T1
FUG_009896-

DUF1295 domain-containing

T1

protein (95.5%)

FUG_011399-

S

DUF967 domain protein
12

2/3

41

T1

S
(69.9%)

FUG_00101416

1/3

23

Hypothetical protein

S

T1
Glutathione-dependent
FUG_00610613

1/3

19

formaldehyde-activating GFA

S

T1
protein (75%)
FUG_007149-

SH3 domain containing
5

1/3

42

T1

S
protein (94.4%)
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FUG_0034757

1/3

37

SMC domain protein (78%)

S

5

1/3

44

Hypothetical protein

S

T1
FUG_009066T1

According to the HRI11 and HRS10 databases, HRI11 database contain more proteins and
most of the proteins are sequentially similar proteins (Shi et al. in preparation). The accession
numbers of each protein in the two databases are different. The HRS10 database has accession
numbers starting from FUG_000001-T1 and HRI11 database has accession numbers starting from
FUN_000001-T1. Therefore, the sequences of 54 candidates (from HRS10-XDR1-3xFLAG and
HRS10-xdr1-3xFLAG) were blasted against the HRI11 database to find out how many proteins of
them are sequentially similar with the HRI11 database. Then the availability of those proteins was
searched in the mass spectrometry data for HRI11 transformants including the HRI11 negative
control. It is important to identify such candidates as those candidates common to both HRS10 and
HRI11 transformants among the 54 should be disregard from the study (Table 7).
Table 7: 54 unique proteins were Blasted against HRI11 database and searched for Mass spec
data for HRI11 transformants.
Availability in

Availability in

Subsequent

Subsequent
HRI11-XDR1-

HRS10 database

accession

accession

number

number

available in

HRI11-XDR1HRS10 database

accession

accession

number

number

available in

3xFLAG and

3xFLAG and

HRI11-xdr1-

HRI11-xdr1-

3xFLAG

3xFLAG

HRIll database

HRIll database
(Yes/No)

FUG_006095-

(Yes/No)

FUN_011465-

FUG_003246-

FUN_008936-

T1

T1

Yes
T1

Yes*

T1
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FUG_006090-

FUN_011470-

FUG_001043-

FUN_002580-

T1

T1

FUG_009006-

FUN_011276-

T1

T1

FUG_009896-

FUN_007280-

T1

T1

FUG_002691-

FUN_003502-

T1

T1

FUG_011399-

FUN_001579-

T1

T1

FUG_006624-

FUN_009177-

T1

T1

FUG_002190-

FUN_010579-

T1

T1

FUG_000266-

FUN_000461-

T2

T1

No
T1

T1

FUG_006091-

FUN_011469-

Yes*

No
T1

T1

FUG_006093-

FUN_011467-

No

No
T1

T1

FUG_004544-

FUN_006037-

Yes**

Yes
T1

T1

FUG_000381-

FUN_000571-

Yes

No
T1

T1

FUG_010180-

FUN_001857-

No

No
T1

T1

FUG_004362-

FUN_010391-

No

No
T1

T1

FUG_002183-

FUN_010587-

Yes*

Yes*
T1

T1

FUG_003634-

FUN_010130-

No

FUG_010280Yes*

FUN_001963

T1

T1

T1

FUG_000599-

FUN_000795-

FUG_007147-

FUN_012155-

T1

T1

T1

T1

FUG_011078-

FUN_009569-

FUG_002885-

FUN_003693-

T1

T1

FUG_005849-

FUN_000119-

T1

T1

FUG_008934-

FUN_011202-

T1

T1

Yes*

Yes*
Yes

Yes*
T1

T1

FUG_001228-

FUN_002395-

Yes*

No
T1

T1

FUG_007029-

FUN_005024-

Yes*

Yes*
T1

Yes

T1
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FUG_001229-

FUN_002394-

FUG_009013-

FUN_011283-

T1

T1

FUG_001014-

FUN_002610-

T1

T1

FUG_006106-

FUN_011453-

T1

T1

FUG_007149-

FUN_012153-

T1

T1

FUG_001750-

FUN_008451-

T1

T1

FUG_002583-

FUN_004136-

T1

T1

FUG_003475-

FUN_006491-

T1

T1

FUG_005748-

FUN_007466-

T1

T1

FUG_009066-

FUN_011340-

T1

T1

FUG_003664-

FUN_010100-

T1

T1

FUG_001007-

FUN_002617-

T1

T1

FUG_002562-

FUN_004158-

T1

T1

FUG_011675-

FUN_001296-

T1

T1

Yes*
T1

T1

FUG_006269-

FUN_002127-

Yes*

No
T1

T1

FUG_002107-

FUN_010663-

No

Yes*
T1

T1

FUG_005493-

FUN_004598-

No

Yes*
T1

T1

FUG_004977-

FUN_005605-

Yes

No
T1

T1

FUG_007069-

FUN_004982-

No

No
T1

T1

FUG_009484-

FUN_002715-

No

Yes*
T1

T1

FUG_002950-

FUN_002815-

Yes

Yes*
T1

T1

FUG_001985-

FUN_010782-

Yes

No
T1

T1

FUG_009957-

FUN_007216-

No

Yes*
T1

T1

FUG_002357-

FUN_004371-

No

No
T1

T1

FUG_011780-

FUN_012357-

No

No
T1

T1

FUG_003241-

FUN_008941-

Yes*

No
T1

Yes*

T1

Yes*: The protein is available in both HRI11-XDR1-3xFLAG and HRI11-xdr1-3xFLAG, and also in HRI11 (the
negative control) at least in one biological replicate, Yes**: The protein is also available in HRI11 other than
HRS10-XDR1-3xFLAG and HRS10-xdr1-3xFLAG, at least in one biological replicate
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Table 7 summarizes the availability of 54 unique candidates in the HRI11 mass spec data.
All the HRS10 sequences had 100% sequence similarity with HRI11 sequences. The “No”
indicates, the peptide is available only for HRS10-XDR1-3xFLAG and HRS10-xdr1-3xFLAG.
The “Yes” indicates the peptide is available also in HRI11-XDR1-3xFLAG and HRI11-xdr13xFLAG at least in one biological replicate. The “Yes*” indicates the protein is available all HRI11
samples/transformants (HRI11, HRI11-XDR1-3xFLAG, and HRI11-xdr1-3xFLAG) at least in
one biological replicate. The “Yes**” indicates the protein is also available in HRI11 other than
HRS10-XDR1-3xFLAG and HRS10-xdr1-3xFLAG, at least in one biological replicate. Therefore,
there are only 25 unique peptides detected unique for HRS10-XDR1-3xFLAG and HRS10-xdr13xFLAG. There are 29 candidate peptides, which were available in both HRS10-XDR10-3xFLAG
and HRS10-xdr1-3xFLAG and also available in at least one biological replicate of the HRI11
transformants and the negative control.
The unique peptides detected in mass spec data for the method 1 was also considered to
check whether any of the nine candidates were detected again in the mass spec data for method 2.
The data summarized in the Table 8.
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Table 8: Unique peptides detected in mass spectrometry for method 1 comparison with
method 2 unique peptides.
Unique

Availability

Availability of

peptide

of method 1

the peptide in

detected in

peptides in

Sample availability in

HRI11 data/

method 1 in

method 2

method 2 mass spec data

Accession

three

mass spec

with its replicates

number for

biological

data

similar HRI11

replicates

(Yes/No)

peptide

Available biological
replicates

FUG_002724No

Method 1: No

Method 2:

Method2: Yes

*HRI11: 2/3

FUN_003536-

*HRI11-XDR1-3xFLAG:2/3

T1

*HRI11-xdr1-3xFLAG:1/3

N/A

T1 (1/3)

Method 1:
*HRI11: 0/3

FUG_003814-

*HRS10: 3/3

Method 1: Yes

*HRI11-XDR1-3xFLAG:1/3

*HRS10-XDR1-

Method 2: Yes

*HRI11-xdr1-3xFLAG:2/3

3xFLAG:3/3

FUN_009951-

Method 2:

*HRS10-xdr1-3xFLAG:3/3

T1

*HRI11: 3/3

Yes
T1 (1/3)

*HRI11-XDR1-3xFLAG:3/3
*HRI11-xdr1-3xFLAG:3/3
Method 1:
*HRI11: 2/3
Method 1: Yes
*HRI11-XDR1-3xFLAG:2/3
FUG_009233-

Method 2: Yes
No

N/A

*HRI11-xdr1-3xFLAG:0/3

T1 (1/3)

FUN_011876Method 2:
T1
*HRI11: 1/3
*HRI11-XDR1-3xFLAG:1/3
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*HRI11-xdr1-3xFLAG:1/3

FUG_004773-

*HRS10:3/3

Method 1: No

Method 2:

*HRS10-XDR1-

Method 2: Yes

*HRI11: 2/3

3xFLAG:2/3

FUN_005806-

*HRI11-XDR1-3xFLAG:3/3

*HRS10-xdr1-3xFLAG:3/3

T1

*HRI11-xdr1-3xFLAG:3/3

*HRS10:3/3

Method 1: No

Method 2:

*HRS10-XDR1-

Method 2: Yes

*HRI11: 3/3

3xFLAG:3/3

FUN_000385-

*HRI11-XDR1-3xFLAG:3/3

*HRS10-xdr1-3xFLAG:3/3

T1

*HRI11-xdr1-3xFLAG:3/3

Yes
T1 (1/3)

FUG_000189Yes
T1 (1/3)

Method 1: No
FUG_008404-

Method 2: No
No

N/A

N/A

T1 (1/3)

FUN_012262T1
Method 1:
*HRI11: 1/3

FUG_010028-

*HRS10:3/3

Method 1: Yes

*HRI11-XDR1-3xFLAG:3/3

*HRS10-XDR1-

Method 2: Yes

*HRI11-xdr1-3xFLAG:0/3

3xFLAG:2/3

FUN_001698-

Method 2:

*HRS10-xdr1-3xFLAG:3/3

T1

*HRI11: 3/3

Yes
T1 (1/3)

*HRI11-XDR1-3xFLAG:3/3
*HRI11-xdr1-3xFLAG:3/3
Method 1:
*HRI11: 1/3
Method 1: Yes
*HRI11-XDR1-3xFLAG:3/3
FUG_000263-

Method 2: Yes
No

N/A

*HRI11-xdr1-3xFLAG:1/3

T1 (1/3)

FUN_000457Method 2:
T1
*HRI11: 1/3
*HRI11-XDR1-3xFLAG:3/3
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*HRI11-xdr1-3xFLAG:1/3
Method 1: No

Method 2:

Method 2: Yes

*HRI11: 0/3

FUN_0010387-

*HRI11-XDR1-3xFLAG:2/3

T1

*HRI11-xdr1-3xFLAG:2/3

*HRS10:1/3
FUG_004358Yes

*HRS10-XDR1-

T1 (1/3)
3xFLAG:1/3

N/A: Data not available

According to Table 8, five peptides from method 1 are detected with method 2 in HRS10
database (FUG_003814-T1, FUG_004773-T1,

FUG_000189-T1,

FUG_010028-T1,

and

FUG_004358-T1). All these five peptides were available only in one biological replicate in method
1 for HRS10 samples/transformants, but they were available in more than one biological replicate
in the method 2 for both HRS10 and HRI11 samples/transformants. Among the nine candidates,
only one peptide was not available in the mass spec data for HRS10 and HRI11
samples/transformants in method 2 (FUG_008404). All other eight candidates of mass spec data
for HRS10 in method 1 were detected in HRI11 samples for at least one method between two and
at least one biological replicate among three. All HRS10 peptide sequences had 100% sequence
similarity with its equivalent protein in HRI11.
With these indications, most of the method 1 peptides were present in HRI11 samples also
and we can conclude that the nine candidates have very low chance of being binding partners for
XDR1 in method 1. However, the 25 unique peptides that were detected uniquely to HRS10XDR1-3xFLAG and HRS10-xdr1-3xFLAG have a higher chance of interacting with XDR1. More
molecular detection and expression data will be required to prove this observation.
In method 2 data, any biological replicate among three of HRS10-xdr1-3xFLAG did not
have visible peaks in normalized spectra, the samples might have included enough xdr1 in order
to be detected in the region common for HRS10-XDR1-3xFLAG and HRS10-xdr1-3xFLAG in
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the Venn diagram (Figure 17b). There is no evidence to identify the normalization as zero, therefore
we cannot come into a conclusion about the normalization spectra regarding to HRS10-xdr13xFLAG.
In future, we also need more experiments to prove the xdr1/XDR1 has a transmembrane
domain which we predicted based on the sequencing data and molecular docking tools.
Additionally, we need biochemical experiments to prove functional understanding of the DNA
binding domain cleave upon binding partner(s) binds to the activation domain.
Since the C. jacksonii database is not available with complete GO terms, we are unable to
obtain the GO biological process enrichment to understand better how each binding partners
interact with XDR1 and other binding partners. Further molecular detection experiments for the
3xFLAG transformants will confirm how each binding partner functionally interacts with XDR1
transcription factor leading to better understand how XDR1 is capable of transcribe Phases I and
III genes for maintain their constitutive overexpression, resulting in multidrug resistance through
xenobiotic detoxification systems.
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